Preliminary immunogenicity and safety results of Phase 1 portion of clinical trial of NVX‑CoV2373 are expected in July 2020.
Considering that on 11 August we have earnings distribution.
When will the results of Phase 1 be published ?
$mrna $ino $nvax $jnj $bcrx $vxrt #biotech